Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

In search of natural substrates and inhibitors of MDR pumps.

Lewis K.

J Mol Microbiol Biotechnol. 2001 Apr;3(2):247-54. Review.

PMID:
11321580
2.

Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor.

Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K.

Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1433-7.

3.

Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial.

Ball AR, Casadei G, Samosorn S, Bremner JB, Ausubel FM, Moy TI, Lewis K.

ACS Chem Biol. 2006 Oct 24;1(9):594-600.

PMID:
17168555
4.

Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials.

Tegos G, Stermitz FR, Lomovskaya O, Lewis K.

Antimicrob Agents Chemother. 2002 Oct;46(10):3133-41.

5.

Multidrug resistance pumps in bacteria: variations on a theme.

Lewis K.

Trends Biochem Sci. 1994 Mar;19(3):119-23. Review.

PMID:
8203018
6.

EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB.

Lomovskaya O, Lewis K, Matin A.

J Bacteriol. 1995 May;177(9):2328-34.

8.

[The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].

Hasdemir U.

Mikrobiyol Bul. 2007 Apr;41(2):309-27. Review. Turkish.

PMID:
17682720
9.

[Efflux-mediated antibiotics resistance in bacteria].

Cattoir V.

Pathol Biol (Paris). 2004 Dec;52(10):607-16. French.

PMID:
15596311
10.

Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.

Wieczorek P, Sacha P, Hauschild T, Zórawski M, Krawczyk M, Tryniszewska E.

Folia Histochem Cytobiol. 2008;46(3):257-67. doi: 10.2478/v10042-008-0056-x. Review.

11.

Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin.

Musumeci R, Speciale A, Costanzo R, Annino A, Ragusa S, Rapisarda A, Pappalardo MS, Iauk L.

Int J Antimicrob Agents. 2003 Jul;22(1):48-53.

PMID:
12842327
12.

Bacteria lacking a multidrug pump: a sensitive tool for drug discovery.

Hsieh PC, Siegel SA, Rogers B, Davis D, Lewis K.

Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6602-6.

13.

Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.

Rieg S, Huth A, Kalbacher H, Kern WV.

Int J Antimicrob Agents. 2009 Feb;33(2):174-6. doi: 10.1016/j.ijantimicag.2008.07.032. Epub 2008 Oct 21.

PMID:
18945595
14.

Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.

Lomovskaya O, Watkins W.

J Mol Microbiol Biotechnol. 2001 Apr;3(2):225-36. Review.

PMID:
11321578
15.

Antibiotic efflux pumps.

Van Bambeke F, Balzi E, Tulkens PM.

Biochem Pharmacol. 2000 Aug 15;60(4):457-70. Review.

PMID:
10874120
16.

Bacterial efflux pump inhibitors from natural sources.

Stavri M, Piddock LJ, Gibbons S.

J Antimicrob Chemother. 2007 Jun;59(6):1247-60. Epub 2006 Dec 4. Review.

PMID:
17145734
17.
18.

The Escherichia coli multidrug transporter MdfA catalyzes both electrogenic and electroneutral transport reactions.

Lewinson O, Adler J, Poelarends GJ, Mazurkiewicz P, Driessen AJ, Bibi E.

Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1667-72. Epub 2003 Feb 10.

19.

Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).

Bohnert JA, Schuster S, Fähnrich E, Trittler R, Kern WV.

J Antimicrob Chemother. 2007 Jun;59(6):1216-22. Epub 2006 Oct 24.

PMID:
17062614
20.

Channel-tunnels: outer membrane components of type I secretion systems and multidrug efflux pumps of Gram-negative bacteria.

Andersen C.

Rev Physiol Biochem Pharmacol. 2003;147:122-65. Epub 2003 Mar 13. Review.

PMID:
12783268

Supplemental Content

Support Center